Supplementary material references
1. de Ligt J, Willemsen MH, van Bon BW, et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med. 2012;367:1921-9. [ Links ]
2. Dimassi S, Labalme A, Ville D, et al. Whole-exome sequencing improves the diagnosis yield in sporadic infantile spasm syndrome. Clin Genet. 2016;89:198-204. [ Links ]
3. Epi4K Consortium, Epilepsy Phenome/Genome Project, Allen AS, et al. De novo mutations in epileptic encephalopathies. Nature. 2013;501:217-21. [ Links ]
4. Michaud JL, Lachance M, Hamdan FF, et al. The genetic landscape of infantile spasms. Hum Mol Genet. 2014;23:4846-58. [ Links ]
5. Møller RS, Dahl HA, Helbig I. The contribution of next generation sequencing to epilepsy genetics. Expert Rev Mol Diagn 2015;15:1531-8. [ Links ]
6. Timal S, Hoischen A, Lehle L, et al. Gene identification in the congenital disorders of glycosylation Type I by whole-exome sequencing. Hum Mol Genet. 2012;21:4151-61. [ Links ]
7. Harvey K, Duguid IC, Alldred MJ, et al. The GDP-GTP exchange factor collybistin:an essential determinant of neuronal gephyrin clustering. J Neurosci. 2004;24:5816-26. [ Links ]
8. Lesca G, Till M, Labalme A, Vallee D, et al. De novo xq11.11 microdeletion including ARHGEF9 in a boy with mental retardation, epilepsy, macrosomia, and dysmorphic features. Am J Med Genet A. 2011;155A:1706-11. [ Links ]
9. Lesca G, Depienne C. Epilepsy genetics:the ongoing revolution. Rev Neurol. 2015;171:539-57. [ Links ]
10. Shimojima K, Sugawara M, Shichiji M, et al. Loss-of-function mutation of collybistin is responsible for X-linked mental retardation associated with epilepsy. J Hum Genet. 2011;56:561-5. [ Links ]
11. Bruyere H, Lewis S, Wood S, MacLeod PJ, Langlois S. Confirmation of linkage in X-linked infantile spasms (West syndrome) and refinement of the disease locus to xp21.3-xp22.1. Clin Genet. 1999;55:173-81. [ Links ]
12. Claes S, Devriendt K, Lagae L, et al. The X-linked infantile spasms syndrome (MIM 308350) maps to xp11.4-xpter in two pedigrees. Ann Neurol. 1997;42:360-4. [ Links ]
13. Feinberg AP, Leahy WR. Infantile spasms:case report of sex-linked inheritance. Dev Med Child Neurol. 1977;19:524-6. [ Links ]
14. Fullston T, Brueton L, Willis T, et al. Ohtahara syndrome in a family with an ARX protein truncation mutation (c.81C>G/p.Y27X). Eur J Hum Genet. 2010;18:157-62. [ Links ]
15. Giordano L, Sartori S, Russo S, et al. Familial ohtahara syndrome due to a novel ARX gene mutation. Am J Med Genet A. 2010;152A:3133-7. [ Links ]
16. Kato M, Das S, Petras K, et al. Mutations of ARX are associated with striking pleiotropy and consistent genotype-phenotype correlation. Hum Mutat. 2004;23:147-59. [ Links ]
17. Kato M, Saitoh S, Kamei A, et al. A longer polyalanine expansion mutation in the ARX gene causes early infantile epileptic encephalopathy with suppression-burst pattern (Ohtahara syndrome). Am J Hum Genet. 2007;81:361-6. [ Links ]
18. Poeta L, Fusco F, Drongitis D, et al. A regulatory path associated with X-linked intellectual disability and epilepsy links KDM5C to the polyalanine expansions in ARX. Am J Hum Genet. 2013;92:114-25. [ Links ]
19. Proud VK, Levine C, Carpenter NJ. New X-linked syndrome with seizures, acquired micrencephaly, and agenesis of the corpus callosum. Am J Med Genet. 1992;43:458-66. [ Links ]
20. Strømme P, Mangelsdorf ME, Shaw MA, et al. Mutations in the human ortholog of aristaless cause X-linked mental retardation and epilepsy. Nat Genet. 2002;30:441-5. [ Links ]
21. Strømme P, Sundet K, Mørk C, et al. X linked mental retardation and infantile spasms in a family:new clinical data and linkage to xp11.4-xp22.11. J Med Genet. 1999;36:374-8. [ Links ]
22. Turner G, Partington M, Kerr B, Mangelsdorf M, Gecz J. Variable expression of mental retardation, autism, seizures, and dystonic hand movements in two families with an identical ARX gene mutation. Am J Med Genet. 2002;112:405-11. [ Links ]
23. Chan YC, Burgunder JM, Wilder-Smith E, et al. Electroencephalographic changes and seizures in familial hemiplegic migraine patients with the CACNA1A gene S218L mutation. J Clin Neurosci. 2008;15:891-4. [ Links ]
24. Chioza B, Wilkie H, Nashef L, et al. Association between the alpha(1a) calcium channel gene CACNA1A and idiopathic generalized epilepsy. Neurology. 2001;56:1245-6. [ Links ]
25. Holtmann M, Opp J, Tokarzewski M, Korn-Merker E. Human epilepsy, episodic ataxia Type 2, and migraine. Lancet. 2002;359:170-1. [ Links ]
26. Jouvenceau A, Eunson LH, Spauschus A, et al. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet. 2001;358:801-7. [ Links ]
27. Kors EE, Melberg A, Vanmolkot KR, et al. Childhood epilepsy, familial hemiplegic migraine, cerebellar ataxia, and a new CACNA1A mutation. Neurology. 2004;63:1136-7. [ Links ]
28. Chen Y, Lu J, Pan H, et al. Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann Neurol. 2003;54:239-43. [ Links ]
29. Heron SE, Khosravani H, Varela D, et al. Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants. Ann Neurol. 2007;62:560-8. [ Links ]
30. Khosravani H, Altier C, Simms B, et al. Gating effects of mutations in the cav3.2 T-type calcium channel associated with childhood absence epilepsy. J Biol Chem. 2004;279:9681-4. [ Links ]
31. Khosravani H, Bladen C, Parker DB, et al. Effects of cav3.2 channel mutations linked to idiopathic generalized epilepsy. Ann Neurol. 2005;57:745-9. [ Links ]
32. Vitko I, Chen Y, Arias JM, et al. Functional characterization and neuronal modeling of the effects of childhood absence epilepsy variants of CACNA1H, a T-type calcium channel. J Neurosci. 2005;25:4844-55. [ Links ]
33. Mefford HC, Yendle SC, Hsu C, et al. Rare copy number variants are an important cause of epileptic encephalopathies. Ann Neurol. 2011;70:974-85. [ Links ]
34. Vergult S, Dheedene A, Meurs A, et al. Genomic aberrations of the CACNA2D1 gene in three patients with epilepsy and intellectual disability. Eur J Hum Genet. 2015;23:628-32. [ Links ]
35. Archer HL, Evans J, Edwards S, et al. CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients. J Med Genet. 2006;43:729-34. [ Links ]
36. Elia M, Falco M, Ferri R, et al. CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy. Neurology. 2008;71:997-9. [ Links ]
37. Bartnik M, Derwińska K, Gos M, et al. Early-onset seizures due to mosaic exonic deletions of CDKL5 in a male and two females. Genet Med. 2011;13:447-52. [ Links ]
38. Erez A, Patel AJ, Wang X, et al. Alu-specific microhomology-mediated deletions in CDKL5 in females with early-onset seizure disorder. Neurogenetics. 2009;10:363-9. [ Links ]
39. Kalscheuer VM, Tao J, Donnelly A, et al. Disruption of the serine/threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation. Am J Hum Genet. 2003;72:1401-11. [ Links ]
40. Nectoux J, Heron D, Tallot M, Chelly J, Bienvenu T. Maternal origin of a novel C-terminal truncation mutation in CDKL5 causing a severe atypical form of rett syndrome. Clin Genet. 2006;70:29-33. [ Links ]
41. Nemos C, Lambert L, Giuliano F, et al. Mutational spectrum of CDKL5 in early-onset encephalopathies:a study of a large collection of French patients and review of the literature. Clin Genet. 2009;76:357-71. [ Links ]
42. Rademacher N, Hambrock M, Fischer U, et al. Identification of a novel CDKL5 exon and pathogenic mutations in patients with severe mental retardation, early-onset seizures and rett-like features. Neurogenetics. 2011;12:165-7. [ Links ]
43. Rosas-Vargas H, Bahi-Buisson N, Philippe C, et al. Impairment of CDKL5 nuclear localisation as a cause for severe infantile encephalopathy. J Med Genet. 2008;45:172-8. [ Links ]
44. Russo S, Marchi M, Cogliati F, et al. Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes. Neurogenetics. 2009;10:241-50. [ Links ]
45. Saletti V, Canafoglia L, Cambiaso P, et al. A CDKL5 mutated child with precocious puberty. Am J Med Genet A. 2009;149A:1046-51. [ Links ]
46. Scala E, Ariani F, Mari F, et al. CDKL5/STK9 is mutated in rett syndrome variant with infantile spasms. J Med Genet. 2005;42:103-7. [ Links ]
47. Tao J, Van Esch H, Hagedorn-Greiwe M, et al. Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Am J Hum Genet. 2004;75:1149-54. [ Links ]
48. Van Esch H, Jansen A, Bauters M, Froyen G, Fryns JP. Encephalopathy and bilateral cataract in a boy with an interstitial deletion of xp22 comprising the CDKL5 and NHS genes. Am J Med Genet A. 2007;143:364-9. [ Links ]
49. Weaving LS, Christodoulou J, Williamson SL, et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet. 2004;75:1079-93. [ Links ]
50. Carvill GL, Heavin SB, Yendle SC, et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet. 2013;45:825-30. [ Links ]
51. Chénier S, Yoon G, Argiropoulos B, et al. CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems. J Neurodev Disord. 2014;6:9. [ Links ]
52. Galizia EC, Myers CT, Leu C, et al. CHD2 variants are a risk factor for photosensitivity in epilepsy. Brain. 2015;138:1198-207. [ Links ]
53. Liu JC, Ferreira CG, Yusufzai T. Human CHD2 is a chromatin assembly ATPase regulated by its chromo-and DNA-binding domains. J Biol Chem. 2015;290:25-34. [ Links ]
54. Lund C, Brodtkorb E, Øye AM, Røsby O, Selmer KK. CHD2 mutations in lennox-gastaut syndrome. Epilepsy Behav. 2014;33:18-21. [ Links ]
55. Rauch A, Wieczorek D, Graf E, et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability:an exome sequencing study. Lancet. 2012;380:1674-82. [ Links ]
56. Suls A, Jaehn JA, Kecskés A, et al. De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with dravet syndrome. Am J Hum Genet. 2013;93:967-75. [ Links ]
57. Thomas RH, Zhang LM, Carvill GL, et al. CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures. Neurology. 2015;84:951-8. [ Links ]
58. Trivisano M, Striano P, Sartorelli J, et al. CHD2 mutations are a rare cause of generalized epilepsy with myoclonic-atonic seizures. Epilepsy Behav. 2015;51:53-6. [ Links ]
59. Dibbens LM, Mullen S, Helbig I, et al. Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy:precedent for disorders with complex inheritance. Hum Mol Genet. 2009;18:3626-31. [ Links ]
60. Helbig I, Mefford HC, Sharp AJ, et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet. 2009;41:160-2. [ Links ]
61. Peñagarikano O, Abrahams BS, Herman EI, et al. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell. 2011;147:235-46. [ Links ]
62. Strauss KA, Puffenberger EG, Huentelman MJ, et al. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N Engl J Med. 2006;354:1370-7. [ Links ]
63. Alakurtti K, Weber E, Rinne R, et al. Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy, EPM1, mutations. Eur J Hum Genet. 2005;13:208-15. [ Links ]
64. Bespalova IN, Adkins S, Pranzatelli M, Burmeister M. Novel cystatin B mutation and diagnostic PCR assay in an unverricht-lundborg progressive myoclonus epilepsy patient. Am J Med Genet. 1997;74:467-71. [ Links ]
65. de Haan GJ, Halley DJ, Doelman JC, et al. Univerricht-lundborg (sic) disease:underdiagnosed in the Netherlands. Epilepsia. 2004;45:1061-3. [ Links ]
66. Di Giaimo R, Riccio M, Santi S, et al. New insights into the molecular basis of progressive myoclonus epilepsy:a multiprotein complex with cystatin B. Hum Mol Genet. 2002;11:2941-50. [ Links ]
67. Lafrenière RG, Rochefort DL, Chrétien N, et al. Unstable insertion in the 5'flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy Type 1, EPM1. Nat Genet. 1997;15:298-302. [ Links ]
68. Lalioti MD, Mirotsou M, Buresi C, et al. Identification of mutations in cystatin B, the gene responsible for the unverricht-lundborg type of progressive myoclonus epilepsy (EPM1). Am J Hum Genet. 1997;60:342-51. [ Links ]
69. Mazarib A, Xiong L, Neufeld MY, et al. Unverricht-lundborg disease in a five-generation arab family:instability of dodecamer repeats. Neurology. 2001;57:1050-4. [ Links ]
70. Pennacchio LA, Lehesjoki AE, Stone NE, et al. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1) Science. 1996;271:1731-4. [ Links ]
71. Virtaneva K, D'Amato E, Miao J, et al. Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet. 1997;15:393-6. [ Links ]
72. Baulac S, Ishida S, Marsan E, et al. Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations. Ann Neurol. 2015;77:675-83. [ Links ]
73. Berkovic SF, Serratosa JM, Phillips HA, et al. Familial partial epilepsy with variable foci:clinical features and linkage to chromosome 22q12. Epilepsia. 2004;45:1054-60. [ Links ]
74. Callenbach PM, van den Maagdenberg AM, Hottenga JJ, et al. Familial partial epilepsy with variable foci in a dutch family:clinical characteristics and confirmation of linkage to chromosome 22q. Epilepsia. 2003;44:1298-305. [ Links ]
75. Dibbens LM, de Vries B, Donatello S, et al. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet. 2013;45:546-51. [ Links ]
76. Ishida S, Picard F, Rudolf G, et al. Mutations of DEPDC5 cause autosomal dominant focal epilepsies. Nat Genet. 2013;45:552-5. [ Links ]
77. Klein KM, O'Brien TJ, Praveen K, et al. Familial focal epilepsy with variable foci mapped to chromosome 22q12:expansion of the phenotypic spectrum. Epilepsia. 2012;53:e151-5. [ Links ]
78. Martin C, Meloche C, Rioux MF, et al. A recurrent mutation in DEPDC5 predisposes to focal epilepsies in the french-canadian population. Clin Genet. 2014;86:570-4. [ Links ]
79. Picard F, Baulac S, Kahane P, et al. Dominant partial epilepsies. A clinical, electrophysiological and genetic study of 19 European families. Brain. 2000;123 (Pt 6):1247-62. [ Links ]
80. Picard F, Makrythanasis P, Navarro V, et al. DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy. Neurology. 2014;82:2101-6. [ Links ]
81. Scheffer IE, Heron SE, Regan BM, et al. Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations. Ann Neurol. 2014;75:782-7. [ Links ]
82. Scheffer IE, Phillips HA, O'Brien CE, et al. Familial partial epilepsy with variable foci:a new partial epilepsy syndrome with suggestion of linkage to chromosome 2. Ann Neurol. 1998;44:890-9. [ Links ]
83. Xiong L, Labuda M, Li DS, et al. Mapping of a gene determining familial partial epilepsy with variable foci to chromosome 22q11-q12. Am J Hum Genet. 1999;65:1698-710. [ Links ]
84. Epilepsy Phenome/Genome Project Epi4K Consortium. Copy number variant analysis from exome data in 349 patients with epileptic encephalopathy. Ann Neurol. 2015;78:323-8. [ Links ]
85. Boumil RM, Letts VA, Roberts MC, et al. A missense mutation in a highly conserved alternate exon of dynamin-1 causes epilepsy in fitful mice. PLoS Genet. 2010;6:e1001046. [ Links ]
86. Deciphering Developmental Disorders Study. Large-scale discovery of novel genetic causes of developmental disorders. Nature. 2015;519:223-8. [ Links ]
87. Dhindsa RS, Bradrick SS, Yao X, et al. Epileptic encephalopathy-causing mutations in DNM1 impair synaptic vesicle endocytosis. Neurol Genet. 2015;1:e4. [ Links ]
88. EuroEPINOMICS-RES Consortium, Epilepsy Phenome/Genome Project, Epi4K Consortium. De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. Am J Hum Genet. 2014;95:360-70. [ Links ]
89. Perrault I, Hamdan FF, Rio M, et al. Mutations in DOCK7 in individuals with epileptic encephalopathy and cortical blindness. Am J Hum Genet. 2014;94:891-7. [ Links ]
90. Carvill GL, Weckhuysen S, McMahon JM, et al. GABRA1 and STXBP1:novel genetic causes of dravet syndrome. Neurology. 2014;82:1245-53. [ Links ]
91. Cossette P, Liu L, Brisebois K, et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet. 2002;31:184-9. [ Links ]
92. Ding L, Feng HJ, Macdonald RL, et al. GABA(A) receptor alpha1 subunit mutation A322D associated with autosomal dominant juvenile myoclonic epilepsy reduces the expression and alters the composition of wild type GABA(A) receptors. J Biol Chem. 2010;285:26390-405. [ Links ]
93. Lachance-Touchette P, Brown P, Meloche C, et al. Novel ?1 and ?2 GABAA receptor subunit mutations in families with idiopathic generalized epilepsy. Eur J Neurosci. 2011;34:237-49. [ Links ]
94. Maljevic S, Krampfl K, Cobilanschi J, et al. A mutation in the GABA(A) receptor alpha(1)-subunit is associated with absence epilepsy. Ann Neurol. 2006;59:983-7. [ Links ]
95. Tanaka M, Olsen RW, Medina MT, et al. Hyperglycosylation and reduced GABA currents of mutated GABRB3 polypeptide in remitting childhood absence epilepsy. Am J Hum Genet. 2008;82:1249-61. [ Links ]
96. Urak L, Feucht M, Fathi N, Hornik K, Fuchs K. A GABRB3 promoter haplotype associated with childhood absence epilepsy impairs transcriptional activity. Hum Mol Genet. 2006;15:2533-41. [ Links ]
97. Audenaert D, Schwartz E, Claeys KG, et al. A novel GABRG2 mutation associated with febrile seizures. Neurology. 2006;67:687-90. [ Links ]
98. Baulac S, Huberfeld G, Gourfinkel-An I, et al. First genetic evidence of GABA(A) receptor dysfunction in epilepsy:a mutation in the gamma2-subunit gene. Nat Genet. 2001;28:46-8. [ Links ]
99. Chaumont S, AndréC, Perrais D, Boué-Grabot E, et al. Agonist-dependent endocytosis of ?-aminobutyric acid Type A (GABAA) receptors revealed by a ?2(R43Q) epilepsy mutation. J Biol Chem. 2013;288:28254-65. [ Links ]
100. Chiu C, Reid CA, Tan HO, et al. Developmental impact of a familial GABAA receptor epilepsy mutation. Ann Neurol. 2008;64:284-93. [ Links ]
101. Frugier G, Coussen F, Giraud MF, et al. A gamma 2(R43Q) mutation, linked to epilepsy in humans, alters GABAA receptor assembly and modifies subunit composition on the cell surface. J Biol Chem. 2007;282:3819-28. [ Links ]
102. Harkin LA, Bowser DN, Dibbens LM, et al. Truncation of the GABA(A)-receptor gamma2 subunit in a family with generalized epilepsy with febrile seizures plus. Am J Hum Genet. 2002;70:530-6. [ Links ]
103. Kananura C, Haug K, Sander T, et al. A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Arch Neurol. 2002;59:1137-41. [ Links ]
104. Kang JQ, Shen W, Macdonald RL. Why does fever trigger febrile seizures?GABAA receptor gamma2 subunit mutations associated with idiopathic generalized epilepsies have temperature-dependent trafficking deficiencies. J Neurosci. 2006;26:2590-7. [ Links ]
105. Sancar F, Czajkowski C. A GABAA receptor mutation linked to human epilepsy (gamma2R43Q) impairs cell surface expression of alphabetagamma receptors. J Biol Chem. 2004;279:47034-9. [ Links ]
106. Tan HO, Reid CA, Single FN, et al. Reduced cortical inhibition in a mouse model of familial childhood absence epilepsy. Proc Natl Acad Sci U S A. 2007;104:17536-41. [ Links ]
107. Wallace RH, Marini C, Petrou S, et al. Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet. 2001;28:49-52. [ Links ]
108. Nakamura K, Kodera H, Akita T, et al. De novo mutations in GNAO1, encoding a g?o subunit of heterotrimeric G proteins, cause epileptic encephalopathy. Am J Hum Genet. 2013;93:496-505. [ Links ]
109. Carvill GL, Regan BM, Yendle SC, et al. GRIN2A mutations cause epilepsy-aphasia spectrum disorders. Nat Genet. 2013;45:1073-6. [ Links ]
110. Endele S, Rosenberger G, Geider K, et al. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet. 2010;42:1021-6. [ Links ]
111. Lesca G, Rudolf G, Bruneau N, et al. GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction. Nat Genet. 2013;45:1061-6. [ Links ]
112. Lemke JR, Lal D, Reinthaler EM, et al. Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet. 2013;45:1067-72. [ Links ]
113. Scheffer IE, Jones L, Pozzebon M, et al. Autosomal dominant rolandic epilepsy and speech dyspraxia:a new syndrome with anticipation. Ann Neurol. 1995;38:633-42. [ Links ]
114. Nava C, Dalle C, Rastetter A, et al. De novo mutations in HCN1 cause early infantile epileptic encephalopathy. Nat Genet. 2014;46:640-5. [ Links ]
115. Bassi MT, Balottin U, Panzeri C, et al. Functional analysis of novel KCNQ2 and KCNQ3 gene variants found in a large pedigree with benign familial neonatal convulsions (BFNC). Neurogenetics. 2005;6:185-93. [ Links ]
116. Berkovic SF, Kennerson ML, Howell RA, et al. Phenotypic expression of benign familial neonatal convulsions linked to chromosome 20. Arch Neurol. 1994;51:1125-8. [ Links ]
117. Biervert C, Schroeder BC, Kubisch C, et al. A potassium channel mutation in neonatal human epilepsy. Science. 1998;279:403-6. [ Links ]
118. Biervert C, Steinlein OK. Structural and mutational analysis of KCNQ2, the major gene locus for benign familial neonatal convulsions. Hum Genet. 1999;104:234-40. [ Links ]
119. Borgatti R, Zucca C, Cavallini A, et al. A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation. Neurology. 2004;63:57-65. [ Links ]
120. Dedek K, Fusco L, Teloy N, Steinlein OK. Neonatal convulsions and epileptic encephalopathy in an italian family with a missense mutation in the fifth transmembrane region of KCNQ2. Epilepsy Res. 2003;54:21-7. [ Links ]
121. del Giudice EM, Coppola G, Scuccimarra G, et al. Benign familial neonatal convulsions (BFNC) resulting from mutation of the KCNQ2 voltage sensor. Eur J Hum Genet. 2000;8:994-7. [ Links ]
122. Heron SE, Cox K, Grinton BE, et al. Deletions or duplications in KCNQ2 can cause benign familial neonatal seizures. J Med Genet. 2007;44:791-6. [ Links ]
123. Saitsu H, Kato M, Koide A, et al. Whole exome sequencing identifies KCNQ2 mutations in ohtahara syndrome. Ann Neurol. 2012;72:298-300. [ Links ]
124. Singh NA, Charlier C, Stauffer D, et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet. 1998;18:25-9. [ Links ]
125. Weckhuysen S, Mandelstam S, Suls A, et al. KCNQ2 encephalopathy:emerging phenotype of a neonatal epileptic encephalopathy. Ann Neurol. 2012;71:15-25. [ Links ]
126. Wuttke TV, Jurkat-Rott K, Paulus W, et al. Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations. Neurology. 2007;69:2045-53. [ Links ]
127. Yang WP, Levesque PC, Little WA, et al. Functional expression of two kvLQT1-related potassium channels responsible for an inherited idiopathic epilepsy. J Biol Chem. 1998;273:19419-23. [ Links ]
128. Zimprich F, Ronen GM, Stögmann W, et al. Andreas rett and benign familial neonatal convulsions revisited. Neurology. 2006;67:864-6. [ Links ]
129. Barcia G, Fleming MR, Deligniere A, et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet. 2012;44:1255-9. [ Links ]
130. Derry CP, Heron SE, Phillips F, et al. Severe autosomal dominant nocturnal frontal lobe epilepsy associated with psychiatric disorders and intellectual disability. Epilepsia. 2008;49:2125-9. [ Links ]
131. Heron SE, Smith KR, Bahlo M, et al. Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet. 2012;44:1188-90. [ Links ]
132. Ishii A, Shioda M, Okumura A, et al. A recurrent KCNT1 mutation in two sporadic cases with malignant migrating partial seizures in infancy. Gene. 2013;531:467-71. [ Links ]
133. Ohba C, Kato M, Takahashi S, et al. Early onset epileptic encephalopathy caused by de novo SCN8A mutations. Epilepsia. 2014;55:994-1000. [ Links ]
134. Vanderver A, Simons C, Schmidt JL, et al. Identification of a novel de novo p.Phe932Ile KCNT1 mutation in a patient with leukoencephalopathy and severe epilepsy. Pediatr Neurol. 2014;50:112-4. [ Links ]
135. Chabrol E, Popescu C, Gourfinkel-An I, et al. Two novel epilepsy-linked mutations leading to a loss of function of LGI1. Arch Neurol. 2007;64:217-22. [ Links ]
136. Fanciulli M, Santulli L, Errichiello L, et al. LGI1 microdeletion in autosomal dominant lateral temporal epilepsy. Neurology. 2012;78:1299-303. [ Links ]
137. Fertig E, Lincoln A, Martinuzzi A, Mattson RH, Hisama FM. Novel LGI1 mutation in a family with autosomal dominant partial epilepsy with auditory features. Neurology. 2003;60:1687-90. [ Links ]
138. Kalachikov S, Evgrafov O, Ross B, et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet. 2002;30:335-41. [ Links ]
139. Morante-Redolat JM, Gorostidi-Pagola A, Piquer-Sirerol S, et al. Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. Hum Mol Genet. 2002;11:1119-28. [ Links ]
140. Nobile C, Michelucci R, Andreazza S, et al. LGI1 mutations in autosomal dominant and sporadic lateral temporal epilepsy. Hum Mutat. 2009;30:530-6. [ Links ]
141. Sirerol-Piquer MS, Ayerdi-Izquierdo A, Morante-Redolat JM, et al. The epilepsy gene LGI1 encodes a secreted glycoprotein that binds to the cell surface. Hum Mol Genet. 2006;15:3436-45. [ Links ]
142. Striano P, de Falco A, Diani E, et al. A novel loss-of-function LGI1 mutation linked to autosomal dominant lateral temporal epilepsy. Arch Neurol. 2008;65:939-42. [ Links ]
143. Depienne C, Bouteiller D, Keren B, et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles dravet syndrome but mainly affects females. PLoS Genet. 2009;5:e1000381. [ Links ]
144. Dibbens LM, Tarpey PS, Hynes K, et al. X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet. 2008;40:776-81. [ Links ]
145. Hynes K, Tarpey P, Dibbens LM, et al. Epilepsy and mental retardation limited to females with PCDH19 mutations can present de novo or in single generation families. J Med Genet. 2010;47:211-6. [ Links ]
146. Kurian MA, Meyer E, Vassallo G, et al. Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy. Brain. 2010;133:2964-70. [ Links ]
147. Poduri A, Chopra SS, Neilan EG, et al. Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy. Epilepsia. 2012;53:e146-50. [ Links ]
148. Shen J, Gilmore EC, Marshall CA, et al. Mutations in PNKP cause microcephaly, seizures and defects in DNA repair. Nat Genet. 2010;42:245-9. [ Links ]
149. Chen WJ, Lin Y, Xiong ZQ, et al. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet. 2011;43:1252-5. [ Links ]
150. Heron SE, Grinton BE, Kivity S, et al. PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am J Hum Genet. 2012;90:152-60. [ Links ]
151. Lee HY, Huang Y, Bruneau N, et al. Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep. 2012;1:2-12. [ Links ]
152. Méneret A, Grabli D, Depienne C, et al. PRRT2 mutations:a major cause of paroxysmal kinesigenic dyskinesia in the European population. Neurology. 2012;79:170-4. [ Links ]
153. Ono S, Yoshiura K, Kinoshita A, et al. Mutations in PRRT2 responsible for paroxysmal kinesigenic dyskinesias also cause benign familial infantile convulsions. J Hum Genet. 2012;57:338-41. [ Links ]
154. Pelzer N, de Vries B, Kamphorst JT, et al. PRRT2 and hemiplegic migraine:a complex association. Neurology. 2014;83:288-90. [ Links ]
155. Schubert J, Paravidino R, Becker F, et al. PRRT2 mutations are the major cause of benign familial infantile seizures. Hum Mutat. 2012;33:1439-43. [ Links ]
156. Striano P, Lispi ML, Gennaro E, et al. Linkage analysis and disease models in benign familial infantile seizures:a study of 16 families. Epilepsia. 2006;47:1029-34. [ Links ]
157. Wang JL, Cao L, Li XH, Hu ZM, Li JD, Zhang JG, et al. Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain. 2011;134:3493-501. [ Links ]
158. Weber YG, Berger A, Bebek N, et al. Benign familial infantile convulsions:linkage to chromosome 16p12-q12 in 14 families. Epilepsia. 2004;45:601-9. [ Links ]
159. Abou-Khalil B, Ge Q, Desai R, et al. Partial and generalized epilepsy with febrile seizures plus and a novel SCN1A mutation. Neurology. 2001;57:2265-72. [ Links ]
160. Baulac S, Gourfinkel-An I, Picard F, et al. A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33. Am J Hum Genet. 1999;65:1078-85. [ Links ]
161. Buoni S, Orrico A, Galli L, et al. SCN1A (2528delG) novel truncating mutation with benign outcome of severe myoclonic epilepsy of infancy. Neurology. 2006;66:606-7. [ Links ]
162. Rojo DC, Hamiwka L, McMahon JM, et al. De novo SCN1A mutations in migrating partial seizures of infancy. Neurology. 2011;77:380-3. [ Links ]
163. Claes L, Del-Favero J, Ceulemans B, et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet. 2001;68:1327-32. [ Links ]
164. Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet. 2005;366:371-7. [ Links ]
165. Escayg A, MacDonald BT, Meisler MH, et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet. 2000;24:343-5. [ Links ]
166. Freilich ER, Jones JM, Gaillard WD, et al. Novel SCN1A mutation in a proband with malignant migrating partial seizures of infancy. Arch Neurol. 2011;68:665-71. [ Links ]
167. Mantegazza M, Gambardella A, Rusconi R, et al. Identification of an nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures. Proc Natl Acad Sci U S A. 2005;102:18177-82. [ Links ]
168. McArdle EJ, Kunic JD, George AL Jr. Novel SCN1A frameshift mutation with absence of truncated nav1.1 protein in severe myoclonic epilepsy of infancy. Am J Med Genet A. 2008;146A:2421-3. [ Links ]
169. Moulard B, Buresi C, Malafosse A. Study of the voltage-gated sodium channel beta 1 subunit gene (SCN1B) in the benign familial infantile convulsions syndrome (BFIC). Hum Mutat. 2000;16:139-42. [ Links ]
170. Mulley JC, Scheffer IE, Petrou S, et al. SCN1A mutations and epilepsy. Hum Mutat. 2005;25:535-42. [ Links ]
171. Ohmori I, Ouchida M, Ohtsuka Y, Oka E, Shimizu K. Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy. Biochem Biophys Res Commun. 2002;295:17-23. [ Links ]
172. Orrico A, Galli L, Grosso S, et al. Mutational analysis of the SCN1A, SCN1B and GABRG2 genes in 150 italian patients with idiopathic childhood epilepsies. Clin Genet. 2009;75:579-81. [ Links ]
173. Petrovski S, Scheffer IE, Sisodiya SM, et al. Lack of replication of association between scn1a SNP and febrile seizures. Neurology. 2009;73:1928-30. [ Links ]
174. Schlachter K, Gruber-Sedlmayr U, Stogmann E, et al. A splice site variant in the sodium channel gene SCN1A confers risk of febrile seizures. Neurology. 2009;72:974-8. [ Links ]
175. Vahedi K, Depienne C, Le Fort D, et al. Elicited repetitive daily blindness:a new phenotype associated with hemiplegic migraine and SCN1A mutations. Neurology. 2009;72:1178-83. [ Links ]
176. Zucca C, Redaelli F, Epifanio R, et al. Cryptogenic epileptic syndromes related to SCN1A:twelve novel mutations identified. Arch Neurol. 2008;65:489-94. [ Links ]
177. Berkovic SF, Heron SE, Giordano L, et al. Benign familial neonatal-infantile seizures:characterization of a new sodium channelopathy. Ann Neurol. 2004;55:550-7. [ Links ]
178. Heron SE, Crossland KM, Andermann E, et al. Sodium-channel defects in benign familial neonatal-infantile seizures. Lancet. 2002;360:851-2. [ Links ]
179. Kamiya K, Kaneda M, Sugawara T, et al. A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline. J Neurosci. 2004;24:2690-8. [ Links ]
180. Liao Y, Anttonen AK, Liukkonen E, et al. SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain. Neurology. 2010;75:1454-8. [ Links ]
181. Malacarne M, Gennaro E, Madia F, et al. Benign familial infantile convulsions:mapping of a novel locus on chromosome 2q24 and evidence for genetic heterogeneity. Am J Hum Genet. 2001;68:1521-6. [ Links ]
182. Ogiwara I, Ito K, Sawaishi Y, et al. De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies. Neurology. 2009;73:1046-53. [ Links ]
183. Sugawara T, Tsurubuchi Y, Agarwala KL, et al. A missense mutation of the na+channel alpha II subunit gene na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc Natl Acad Sci U S A. 2001;98:6384-9. [ Links ]
184. Blanchard MG, Willemsen MH, Walker JB, et al. De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy. J Med Genet. 2015;52:330-7. [ Links ]
185. de Kovel CG, Meisler MH, Brilstra EH, et al. Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy. Epilepsy Res. 2014;108:1511-8. [ Links ]
186. Veeramah KR, O'Brien JE, Meisler MH, et al. De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. Am J Hum Genet. 2012;90:502-10. [ Links ]
187. Arsov T, Mullen SA, Rogers S, et al. Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Ann Neurol. 2012;72:807-15. [ Links ]
188. Striano P, Weber YG, Toliat MR, et al. GLUT1 muations are a rare cause of familial idiopathic generalized epilepsy. Neurology. 2012;78:557-62. [ Links ]
189. Suls A, Mullen SA, Weber YG, et al. Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1. Ann Neurol. 2009;66:415-9. [ Links ]
190. Molinari F, Raas-Rothschild A, Rio M, et al. Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy. Am J Hum Genet. 2005;76:334-9. [ Links ]
191. Poduri A, Heinzen EL, Chitsazzadeh V, et al. SLC25A22 is a novel gene for migrating partial seizures in infancy. Ann Neurol. 2013;74:873-82. [ Links ]
192. Hamdan FF, Saitsu H, Nishiyama K, et al. Identification of a novel in-frame de novo mutation in SPTAN1 in intellectual disability and pontocerebellar atrophy. Eur J Hum Genet. 2012;20:796-800. [ Links ]
193. Nonoda Y, Saito Y, Nagai S, et al. Progressive diffuse brain atrophy in west syndrome with marked hypomyelination due to SPTAN1 gene mutation. Brain Dev. 2013;35:280-3. [ Links ]
194. Saitsu H, Tohyama J, Kumada T, et al. Dominant-negative mutations in alpha-II spectrin cause west syndrome with severe cerebral hypomyelination, spastic quadriplegia, and developmental delay. Am J Hum Genet. 2010;86:881-91. [ Links ]
195. Hamdan FF, Piton A, Gauthier J, et al. De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsy. Ann Neurol. 2009;65:748-53. [ Links ]
196. Saitsu H, Kato M, Mizuguchi T, et al. De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat Genet. 2008;40:782-8. [ Links ]
197. Edvardson S, Baumann AM, Mühlenhoff M, et al. West syndrome caused by ST3Gal-III deficiency. Epilepsia. 2013;54:e24-7. [ Links ]
198. Berryer MH, Hamdan FF, Klitten LL, et al. Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency. Hum Mutat. 2013;34:385-94. [ Links ]
199. Mignot C, von Stülpnagel C, Nava C, et al. Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy. J Med Genet. 2016;53:511-22. [ Links ]
200. Basel-Vanagaite L, Hershkovitz T, Heyman E, et al. Biallelic SZT2 mutations cause infantile encephalopathy with epilepsy and dysmorphic corpus callosum. Am J Hum Genet. 2013;93:524-9. [ Links ]
201. Corbett MA, Bahlo M, Jolly L, et al. A focal epilepsy and intellectual disability syndrome is due to a mutation in TBC1D24. Am J Hum Genet. 2010;87:371-5. [ Links ]
202. Duru N, Iseri SA, Selçuk N, Tolun A. Early-onset progressive myoclonic epilepsy with dystonia mapping to 16pter-p13.3. J Neurogenet. 2010;24:207-15. [ Links ]
203. Falace A, Filipello F, La Padula V, et al. TBC1D24, an ARF6-interacting protein, is mutated in familial infantile myoclonic epilepsy. Am J Hum Genet. 2010;87:365-70. [ Links ]
204. Guven A, Tolun A. TBC1D24 truncating mutation resulting in severe neurodegeneration. J Med Genet. 2013;50:199-202. [ Links ]
205. Milh M, Falace A, Villeneuve N, et al. Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy. Hum Mutat. 2013;34:869-72. [ Links ]
206. Zara F, Gennaro E, Stabile M, et al. Mapping of a locus for a familial autosomal recessive idiopathic myoclonic epilepsy of infancy to chromosome 16p13. Am J Hum Genet. 2000;66:1552-7. [ Links ]